skip to content

Cambridge Public Health


Justin Christopehr Yang is a doctoral student in the Department of Public Health and Primary Care at the University of Cambridge under the supervision of Professor Carol Brayne and Dr. Andres Roman-Urrestarazu. His research interests primarily lie in the social and economic epidemiology of substance-related use disorders and related health disparities by examining such measures as prevalence of substance use by subpopulations and unmet need for treatment.
Before starting his PhD, Justin worked as a Senior Associate at Avalere Health’s Reimbursement and Market Access practice where he helped multinational life science companies, patient advocates, and charitable foundations solve coverage, coding, payment, and patient access problems facing drugs, biologics, and medical devices. In particular, Justin helped develop tailored product launch strategies, tactical product lifecycle management insights, and data analytic models to support business decisions.

Publications from Elements

Journal articles

2019 (Accepted for publication)

  • Neicun, J., Steenhuizen, M., van Kessel, R., Yang, JC., Negri, A., Czabanowska, K., Corazza, O. and Roman Urrestarazu, A., 2019 (Accepted for publication). Mapping Novel Psychoactive Substances Policy in the EU: the case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden PLoS ONE,
  • 2019

  • Roman-Urrestarazu, A., Yang, J., Robertson, R., McCallum, A., Gray, C., McKee, M. and Middleton, J., 2019. Brexit threatens the UK's ability to tackle illicit drugs and organised crime: What needs to happen now? Health Policy, v. 123
    Doi: 10.1016/j.healthpol.2019.04.005
  • Rosner, B., Neicun, J., Yang, JC. and Roman-Urrestarazu, A., 2019. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence. PLoS One, v. 14
    Doi: 10.1371/journal.pone.0221153
  • Yang, JC., Roman-Urrestarazu, A., McKee, M. and Brayne, C., 2019. Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002-16: evidence from the national surveys on drug use and health. Int J Equity Health, v. 18
    Doi: 10.1186/s12939-019-1026-y
  • Yang, JC., Roman-Urrestarazu, A. and Brayne, C., 2019. Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17. PLoS One, v. 14
  • 2018 (Accepted for publication)

  • Yang, JC., Roman-Urrestarazu, A. and Brayne, C., 2018 (Accepted for publication). Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States PloS one, v. 13
    Doi: 10.1371/journal.pone.0199741
  • Roman Urrestarazu, AE., Yang, J., Ettelt, S., Thalmann, I., Seguel-Ravest, V. and Brayne, C., 2018 (Accepted for publication). Private Health Insurance in Germany and Chile: Two Stories of Co-Existence, Segmentation and Conflict International Journal of Equity in Health,
  • 2018

  • Roman-Urrestarazu, A., Robertson, R., Yang, J., McCallum, A., Gray, C., McKee, M. and Middleton, J., 2018. European Monitoring Centre for Drugs and Drug Addiction has a vital role in the UK's ability to respond to illicit drugs and organised crime. BMJ, v. 362
    Doi: 10.1136/bmj.k4003